THE OPPORTUNITY

WHP Engineering Ltd (known as ‘WHP’) is a specialist engineering company; supplying turnkey, design and build services for highly regulated environments and complex manufacturing processes.

Since it was founded in 2006, WHP had developed a great reputation with some of the biggest global names in the pharmaceutical, biotech and industrial sectors. Manging that growth combined with a difficult onerous contract had resulted in cash flow pressures which meant an equity solution was required in an accelerated timeframe.

Enact moved quickly in September 2016 to secure the future of the business, stabilise it and position it for future growth. 

THE IMPACT SO FAR

Since Enact’s investment the management team has been strengthened and that team has driven an increase in annual turnover of over 300% to £35m.

As a result of this the management team were awarded the BVCA Transformational management team of the year at a national award ceremony in 2019.

Since then the business has continued to deliver significant projects including a viral vector manufacturing facility for Oxford Biomedica, a new Enzyme manufacturing facility for Biocatalysts and a GMP manufacturing facility to manufacture Synthetic NDA establishing it as the “go-to” provider in its chosen markets.